CRED Optimising Regulatory Strategies for Orphan Drugs

Are you looking to understand regulatory processes that speed up approval and access for rare disease treatments?

Our upcoming Optimising Regulatory Strategies for Orphan Drugs CRED course provides essential information on these procedures, along with practical guidance on how to navigate the opportunities and challenges offered by orphan drug regulations.

This online training course will be delivered by expert speakers from health authorities and industry including Biogen, CATS Consultants GmbH and Ipsen.

By attending this online training course on 26 November 2024, you will:

✅ Acquire key information about regulatory processes intended to expedite early access to innovative medicines

✅ Get practical advice on how to prepare and manage orphan submissions

✅ Engage in hands-on case studies and interactive sessions

✅ Build a network that will support you for the rest of your career

✅ Earn 8 CPD hours

This course is part of our programme of CRED courses which are for experienced professionals committed to developing their regulatory and management competencies. 

Discounted rates are available for those working for regulatory or government agencies, academic institutions, charities, patient groups, or in full-time education.